Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Context, ethics and pharmacogenetics.

Adam M Hedgecoe1

  • 1Department of Sociology, School of Social Sciences, University of Sussex, Falmer, Brighton BN1 9QN, UK. A.M.Hedgecoe@sussex.ac.uk

Studies in History and Philosophy of Biological and Biomedical Sciences
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trust and regulatory organisations: the role of local knowledge and facework in research ethics review.

Social studies of science·2012
Same author

It's money that matters: the financial context of ethical decision-making in modern biomedicine.

Sociology of health & illness·2006
Same author

Genetic databases and pharmacogenetics: introduction.

Studies in history and philosophy of biological and biomedical sciences·2006
Same author

Putting pharmacogenetics into practice.

Nature biotechnology·2006
Same author

Critical bioethics: beyond the social science critique of applied ethics.

Bioethics·2004
Same author

Expansion and uncertainty: cystic fibrosis, classification and genetics.

Sociology of health & illness·2003

This study explores clinician attitudes towards pharmacogenetics, finding their acceptance is crucial for integrating this genetic testing into patient care. Understanding these views is key to overcoming implementation barriers.

Area of Science:

  • Pharmacogenetics
  • Clinical Genetics
  • Medical Ethics

Background:

  • Existing literature on pharmacogenetics implementation primarily addresses institutional barriers (funding, regulation).
  • Ethical considerations of pharmacogenetics are often downplayed compared to traditional genetic testing.
  • Limited research exists on clinician acceptance and the impact of pharmacogenetics on clinical practice.

Purpose of the Study:

  • To investigate clinician attitudes towards pharmacogenetic testing.
  • To explore ethical views on pharmacogenetics, including patient exclusion from treatment.
  • To compare clinician perspectives with existing literature on pharmacogenetics implementation.

Main Methods:

  • Qualitative study involving interviews with clinicians.

Related Experiment Videos

  • Focus on specialists in breast cancer and Alzheimer's disease.
  • Analysis of clinician views on pharmacogenetics and its integration into practice.

    • Main Results:

    • Clinician acceptance and attitudes significantly influence pharmacogenetics adoption.
    • Ethical concerns arise regarding pharmacogenetic testing, particularly patient exclusion.
    • Clinical practice integration requires addressing clinician perspectives.

    Conclusions:

    • Clinician attitudes are a critical, yet under-researched, factor in pharmacogenetics implementation.
    • Ethical debates surrounding pharmacogenetics need to incorporate clinical realities.
    • Bridging the gap between literature and clinical practice is essential for successful pharmacogenetics integration.